Fisher & Paykel Healthcare Corporation Limited
Fisher & Paykel Healthcare Corporation Limited
- P/E ratio
- 60.77
Your view on FPH.AX
Overview
What the company does, where it operates, and who runs it.
About Fisher & Paykel Healthcare Corporation Limited
- Industry
- Medical - Instruments & Supplies
- Sector
- Healthcare
- CEO
- Lewis G. Gradon
- Headquarters
- 15 Maurice Paykel Place, Auckland, AUK, NZ
- Industry
- Medical - Instruments & Supplies
- Sector
- Healthcare
- CEO
- Lewis G. Gradon
- Headquarters
- 15 Maurice Paykel Place, Auckland, AUK, NZ
Fisher & Paykel Healthcare Corporation Limited, operating with its various subsidiaries, is a global innovator in medical device technology. The company specializes in the design, production, and worldwide distribution of sophisticated products and systems.
These solutions primarily cater to acute and chronic respiratory care, support during surgical procedures, and the treatment of obstructive sleep apnea (OSA) in both clinical settings and home environments.
Their product lineup includes notable items such as the Airvo 2, a humidified nasal high flow system; Optiflow, designed for nasal high flow therapy; and the F&P 850 System, which offers both non-invasive and invasive ventilation capabilities.
For infant care, the company supplies respiratory products used in resuscitation, continuous positive airway pressure (CPAP) therapy, and nasal high flow therapy. Hospital-grade offerings comprise humidification devices, breathing circuits, chambers, diverse masks, nasal cannulas, surgical accessories, and various interfaces.
For homecare users, Fisher & Paykel provides masks, CPAP devices, data management software, humidifiers, and complementary accessories. Established in 1934, the company maintains its headquarters in Auckland, New Zealand.
Stock Data
Price chart, volume, and trading data.
FRC Fair Value Algorithm
What the FRC Fair Value algorithm says it is worth vs. the current price — FRC's own, on every stock.
About this section
Fair value for Fisher & Paykel Healthcare Corporation Limited from FRC's valuation model, read against the market price. FPH.AX last traded at AUD 34.94, 60.8× trailing earnings — the estimate is read against that market price. The model runs on every stock on the platform and shows the estimate per share and the date it was calculated. A free account covers 3 company valuations a month; a paid subscription is unlimited.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
About this section
Valuation, profitability, liquidity and leverage ratios for Fisher & Paykel Healthcare Corporation Limited. Starting points for Fisher & Paykel Healthcare Corporation Limited: P/E 60.8, EPS AUD 0.80, beta 0.89 — an Medical - Instruments & Supplies name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.
Dividend Analysis
Yield, payout ratio, and dividend coverage metrics.
About this section
Dividend history, yield and payout sustainability for Fisher & Paykel Healthcare Corporation Limited. Fisher & Paykel Healthcare Corporation Limited does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
About this section
Reported vs. expected earnings history for Fisher & Paykel Healthcare Corporation Limited. Trailing twelve-month EPS for Fisher & Paykel Healthcare Corporation Limited stands at AUD 0.80. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.
Wall Street Analyst Estimates
Analysts' price targets, ratings, and revenue and EPS estimates.
Earnings per share estimates
| Per share | This quarterJun 2025 | Next quarterSep 2025 | This yearYear to Mar 2027 | Next yearYear to Mar 2028 |
|---|---|---|---|---|
| Average estimate | NZD 0.00 | NZD 0.34 | NZD 0.96 | NZD 1.11 |
| Lowest estimate | NZD 0.00 | NZD 0.34 | NZD 0.92 | NZD 1.02 |
| Highest estimate | NZD 0.00 | NZD 0.34 | NZD 0.99 | NZD 1.15 |
| Number of analysts | 0 | 1 | 8 | 8 |
| A year ago | NZD 0.20 | NZD 0.28 | NZD 0.80 | — |
| Growth vs a year ago | −100.0% | +21.3% | +20.1% | — |
Revenue estimates
| Total | This quarterJun 2025 | Next quarterSep 2025 | This yearYear to Mar 2027 | Next yearYear to Mar 2028 |
|---|---|---|---|---|
| Average estimate | NZD 1.25B | NZD 1.07B | NZD 2.60B | NZD 2.90B |
| Lowest estimate | NZD 1.25B | NZD 1.07B | NZD 2.56B | NZD 2.81B |
| Highest estimate | NZD 1.25B | NZD 1.07B | NZD 2.65B | NZD 2.96B |
| Number of analysts | 4 | 1 | 16 | 16 |
| A year ago | NZD 570.90M | NZD 692.80M | NZD 2.36B | — |
| Growth vs a year ago | +118.9% | +53.9% | +10.3% | — |
Financial Statements
Income statement, balance sheet, and cash flow statements.
About this section
Income statement, balance sheet and cash flow history for Fisher & Paykel Healthcare Corporation Limited. Fisher & Paykel Healthcare Corporation Limited has reported as a listed company since 2001. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.
Comparables
List of peer companies in the same industry.
| Ticker | Type | Company | Sector | Industry | Mkt cap |
|---|---|---|---|---|---|
| BAXBaxter International Inc. | Healthcare | Medical - Instruments & Supplies | $13.5B | ||
| BDXBecton, Dickinson and Company | Healthcare | Medical - Instruments & Supplies | $58.9B | ||
| COOThe Cooper Companies, Inc. | Healthcare | Medical - Instruments & Supplies | $11.6B | ||
| MMSIMerit Medical Systems, Inc. | Healthcare | Medical - Instruments & Supplies | $5.1B | ||
| RMDResMed Inc. | Healthcare | Medical - Instruments & Supplies | $34.1B | ||
| Ticker | Type | Company | Sector | Exchange | Mkt cap |
|---|---|---|---|---|---|
| HOCPFHOYA Corporation | Healthcare | OTC | $64.6B | ||
| HOCPYHOYA Corporation | Healthcare | OTC | $63.6B | ||
| HRALHear AtLast Holdings, Inc. | Healthcare | OTC | $396 | ||
| ICUIICU Medical, Inc. | Healthcare | NASDAQ | $4.5B | ||
| IMTHInnovative MedTech Inc. | Healthcare | OTC | $89,758 | ||
| INNDInnerScope Hearing Technologies, Inc. | Healthcare | OTC | $2,756 | ||
| ISRGIntuitive Surgical, Inc. | Healthcare | NASDAQ | $145.9B | ||
| JNDOFJINS HOLDINGS Inc. | Healthcare | OTC | $531.0M | ||
| KMTSKESTRA MEDICAL TECHNOLOGIES, LTD. | Healthcare | NASDAQ | $1.7B | ||
| KRMDKORU Medical Systems, Inc. | Healthcare | NASDAQ | $149.6M | ||
| KSRBFKossan Rubber Industries Bhd | Healthcare | OTC | $841.7M | ||
| LFPILifePoint, Inc. | Healthcare | OTC | $2,086 | ||
| Ticker | Fund | Fund assets | % of the fund |
|---|---|---|---|
| VAS.AXVanguard Australian Shares Index ETF | $27.0B in assets | 0.25% | |
| A200.AXBetaShares - Australia 200 ETF | $11.4B in assets | 0.27% | |
| IOZ.AXiShares Core S&P/ASX 200 ETF | $9.8B in assets | 0.27% | |
| STW.AXState Street SPDR S&P/ASX 200 ETF | $6.6B in assets | 0.27% | |
| FAIR.AXBetaShares - Australian Sustainability Leaders ETF | $1.1B in assets | 1.42% | |
| EX20.AXBetaShares - Australian Ex-20 Portfolio Diversifier ETF | $687M in assets | 0.75% | |
| GEAR.AXBetaShares - Geared Australian Equities Complex ETF | $554M in assets | 0.57% | |
Largest holders first, then the funds most concentrated in FPH.AX.
News
Latest headlines and market coverage.
About this section
Latest headlines and company announcements for Fisher & Paykel Healthcare Corporation Limited. Coverage tracks Fisher & Paykel Healthcare Corporation Limited within Medical - Instruments & Supplies (Healthcare). Press releases and market coverage, newest first.

Comments
Comments and replies from FRC members about this company.
No comments yet
Be the first to ask a question or say what you make of Fisher & Paykel Healthcare Corporation Limited.